Alnylam Pharmaceuticals shares owned by Baystate Wealth Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Baystate Wealth Management
from 13F filings
Historical chart of Baystate Wealth Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Baystate Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Baystate Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $101k | 527 | 191.41 |
| 2023-09-30 | $93k | 527 | 177.10 |
| 2023-06-30 | $100k | 527 | 189.94 |
| 2023-03-31 | $106k | 527 | 200.32 |
| 2022-12-31 | $125k | 527 | 237.19 |
| 2022-09-30 | $105k | 527 | 199.24 |
| 2022-06-30 | $77k | 527 | 146.11 |
| 2022-03-31 | $86k | 527 | 163.19 |
| 2021-12-31 | $179k | 1.1k | 169.67 |
| 2021-09-30 | $199k | 1.1k | 188.63 |
| 2021-06-30 | $179k | 1.1k | 169.67 |
| 2021-03-31 | $149k | 1.1k | 141.23 |
| 2016-12-31 | $19k | 460 | 41.30 |
More positions owned by Baystate Wealth Management
View all positions for Baystate Wealth Management